BioSpace News Archive

Deals

Gilead Sciences to Acquire Immunomedics

Gilead Adds TrodelvyTM, First-in-Class Antibody-Drug Conjugate Approved to Treat Triple-Negative Breast Cancer, With Promise in Other Forms of Breast Cancer and Additional Solid Tumors

September 13, 2020
·
16 min read
Drug Development

89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH

89bio, Inc. announced that the company plans to share topline safety, tolerability and efficacy data from its Phase 1b/2a study of BIO89-100 in NASH in a pre-market press release and webcast to be held on Monday, September 14, 2020.

September 13, 2020
·
1 min read
Policy

Statement from the Chief Public Health Officer of Canada on September 13, 2020

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

September 13, 2020
·
2 min read
Genetown

Frequency Therapeutics Presents Results Demonstrating Sustained Improvement in Hearing Loss Patients Treated with FX-322

Evidence of Durable Hearing Improvements in Follow-Up with Patients from Phase 1/2 Study; Speech Intelligibility and Audibility Sustained for Up to 21 Months After Initial Dosing

September 13, 2020
·
10 min read
Policy

Gannex Filed US IND for Its NASH Drug ASC42, an FXR Agonist

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces that it has filed investigational new drug application with US FDA for its non-alcoholic steatohepatitis drug candidate ASC42.

September 13, 2020
·
3 min read
Genetown

EMD Serono Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020

New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer

September 13, 2020
·
19 min read
Cell Culture Market: Chemically Defined Mediums Adaptation to Boost Market Growth

In a recent report by Transparency Market Research, the cell culture market is rapidly being adopted in the field of pharmaceuticals.

September 13, 2020
·
5 min read
Anxiety and Panic Disorders Drugs Market Key Trend is the Combination of Medication and Neuromodulation Devices

One of the key growth promoting factors for this market is daily stress of life and that keeps on increasing.

September 13, 2020
·
5 min read
Policy

AHF: 100% Transparency on COVID-19 Vaccine Trials Is Essential to Public Trust

Despite a widely-touted recent joint pledge of prudence and caution on trial safety by 9 drug companies working on COVID-19 vaccines, most—especially Pfizer and AstraZenca—fall far short on transparency

September 13, 2020
·
4 min read
Corporate Wellness Market: Health Risk Assessment Takes the Lead across Global Firms

Employee welfare is gaining center-stage as across countries, governments demand it and companies witness benefits accrue on account of better employee well-being.

September 13, 2020
·
5 min read